DMBA-SIL-Mal-MMAE

DMBA-SIL-Mal-MMAE, a cytotoxin-linker conjugate designed for antibody-drug conjugates (ADC), exhibits significant antitumor activity. It incorporates the anti-mitotic agent monomethyl auristatin E (MMAE, a tubulin inhibitor) via the linker DMBA-SIL-Mal [1].

[C@H]([C@H](C(N[C@@H]([C@@H](O)C1=CC=CC=C1)C)=O)C)(OC)[C@]2(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(C(OC(C(NCCOCCOCCOCCOCCN3C(=O)C=CC3=O)=O)C4=CC=C(NC(OCC5=CC(OC)=CC(OC)=C5)=O)C=C4)=O)C)C(C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC2)[H]